APPLICATION
ANDA200980
TYPE
ANDA
ORIGINAL APPROVAL
2013-06-12
LATEST ACTION
2015-09-24
ROUTE
ORAL, ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
NORETHINDRONEPrescription
NORETHINDRONE 0.35MG · TABLET · ORAL-28
Approval history
2015-09-24Labeling · Supplement 1 · standardAP
2013-06-12Not Applicable · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.